A conceptual framework for integrating sustainable development goals in radiopharmaceuticals and nuclear medicine

The advent of the Sustainable Development Goals (SDGs) by the United Nations (UN) in 2015 has redefined global development priorities, emphasizing the intertwined objectives of eradicating poverty, ensuring health, and promoting environmental sustainability. This review critically examines the role of radiopharmaceuticals and nuclear medicine in advancing these goals, particularly SDG 3 (Good Health and Well-being). Radiopharmaceuticals and nuclear medicine provide unparalleled precision in diagnosing and treating various diseases, including cancer, cardiovascular, and neurological disorders, thus enhancing global health outcomes and reducing healthcare disparities. Despite their transformative potential, integrating these technologies into global health systems faces significant challenges. Key among these are issues of accessibility and affordability, especially in low- and middle-income countries and environmental sustainability concerns related to the production and disposal of radioactive materials. Addressing these challenges is imperative to align with SDG 12 and SDG 13. Future directions for the field must prioritize innovation, sustainability, and international collaboration. This includes the development of novel radiopharmaceuticals with improved diagnostic and therapeutic efficacy, adopting environmentally friendly synthesis methods, and harmonising regulatory frameworks to facilitate global accessibility. Strengthening global partnerships and enhancing capacity building through targeted educational initiatives are essential to bridge the gap between high-income and low-income regions. In conclusion, radiopharmaceuticals and nuclear medicine are poised to be critical components in achieving the UN' SDGs. These technologies can significantly impact global health, foster socio-economic growth, and contribute to a sustainable and equitable future through concerted efforts in innovation, sustainable practices, and international cooperation.

Authors

Institutions

Publication Details

Journal
Discover Medicine
Published
2025-09-04
DOI
https://doi.org/10.1007/s44337-025-00454-y
Citations
2
Primary Topic
Science, Research, and Medicine
Type
article
Field-Weighted Citation Impact
3.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A conceptual framework for integrating sustainable development goals in radiopharmaceuticals and nuclear medicine

María Emilia Tejería, Antonio Shegani, Charalampos Triantis, Vassilios Makrakis et al.
2 citations
Discover Medicine
Science, Research, and Medicine
3.40
article

A conceptual framework for integrating sustainable development goals in radiopharmaceuticals and nuclear medicine

María Emilia Tejería, Antonio Shegani, Charalampos Triantis, Vassilios Makrakis, Kazuma Ogawa
article en
2 citations

Abstract

The advent of the Sustainable Development Goals (SDGs) by the United Nations (UN) in 2015 has redefined global development priorities, emphasizing the intertwined objectives of eradicating poverty, ensuring health, and promoting environmental sustainability. This review critically examines the role of radiopharmaceuticals and nuclear medicine in advancing these goals, particularly SDG 3 (Good Health and Well-being). Radiopharmaceuticals and nuclear medicine provide unparalleled precision in diagnosing and treating various diseases, including cancer, cardiovascular, and neurological disorders, thus enhancing global health outcomes and reducing healthcare disparities. Despite their transformative potential, integrating these technologies into global health systems faces significant challenges. Key among these are issues of accessibility and affordability, especially in low- and middle-income countries and environmental sustainability concerns related to the production and disposal of radioactive materials. Addressing these challenges is imperative to align with SDG 12 and SDG 13. Future directions for the field must prioritize innovation, sustainability, and international collaboration. This includes the development of novel radiopharmaceuticals with improved diagnostic and therapeutic efficacy, adopting environmentally friendly synthesis methods, and harmonising regulatory frameworks to facilitate global accessibility. Strengthening global partnerships and enhancing capacity building through targeted educational initiatives are essential to bridge the gap between high-income and low-income regions. In conclusion, radiopharmaceuticals and nuclear medicine are poised to be critical components in achieving the UN' SDGs. These technologies can significantly impact global health, foster socio-economic growth, and contribute to a sustainable and equitable future through concerted efforts in innovation, sustainable practices, and international cooperation.

Discover MedicineVol. 2(1)
Kanazawa University (JP), King's College London (GB), Frederick University (CY), Kings Health Partners (GB), Universidad de Montevideo (UY)
Openalex Percentile: Top 7%
Science, Research, and Medicine
3.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.